The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer

gan Beaver, Julia A, Park, Ben H
Cyhoeddwyd 2012

Needles in a haystack: finding recurrent genomic changes in breast cancer

gan Cidado, Justin, Beaver, Julia A, Park, Ben Ho
Cyhoeddwyd yn Breast Cancer Res (2012)

Patient‐Friendly Language to Facilitate Treatment Choice for Patients with Cancer

gan Kim, Janice, Gao, Jennifer, Amiri‐Kordestani, Laleh, Beaver, Julia A., Kluetz, Paul
Cyhoeddwyd yn Oncologist (2019)

Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma

gan Ning, Yang‐Min, Maher, V. Ellen, Beaver, Julia A., Goldberg, Kirsten B., Blumenthal, Gideon M., Pazdur, Richard
Cyhoeddwyd yn Oncologist (2017)

An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies

gan Beaver, Julia A., Tzou, Abraham, Blumenthal, Gideon M., McKee, Amy E., Kim, Geoffrey, Pazdur, Richard, Philip, Reena
Cyhoeddwyd yn Clin Cancer Res (2016)

Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs

gan Kim, Janice, Nair, Abhilasha, Keegan, Patricia, Beaver, Julia A., Kluetz, Paul G., Pazdur, Richard, Chuk, Meredith, Blumenthal, Gideon M.
Cyhoeddwyd yn Oncologist (2019)

Patient‐Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019

gan Bhatnagar, Vishal, Hudgens, Stacie, Piault‐Louis, Elisabeth, Jones, Lee, Beaver, Julia A., Lyerly, H. Kim, Reaman, Gregory, Fleming, Thomas, Kluetz, Paul G.
Cyhoeddwyd yn Oncologist (2020)

Advancing Drug Development in Gynecologic Malignancies

gan Beaver, Julia A., Coleman, Robert L., Arend, Rebecca C., Armstrong, Deborah K., Bala, Sanjeeve, Mills, Gordon B., Sood, Anil K., Herzog, Thomas J.
Cyhoeddwyd yn Clin Cancer Res (2019)

PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system

gan Beaver, Julia A., Gustin, John P., Yi, Kyung H., Rajpurohit, Anandita, Thomas, Matthew, Gilbert, Samuel F., Rosen, D. Marc, Park, Ben Ho, Lauring, Josh
Cyhoeddwyd 2013

Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials

gan Kluetz, Paul G, King-Kallimanis, Bellinda L, Suzman, Daniel, Chang, Elaine, Brave, Michael M, Weinstock, Chana, Bhatnagar, Vishal, Beaver, Julia A, Chuk, Meredith K
Cyhoeddwyd yn J Natl Cancer Inst (2020)

Global Variation in Opioid Use in Prostate Cancer Trials

gan Roydhouse, Jessica K., Suzman, Daniel L., Menapace, Laurel A., Mishra-Kalyani, Pallavi S., Sridhara, Rajeshwari, Blumenthal, Gideon M., Beaver, Julia A., Pazdur, Richard, Kluetz, Paul G.
Cyhoeddwyd yn JAMA Oncol (2019)

US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments

gan Wedam, Suparna B., Beaver, Julia A., Amiri-Kordestani, Laleh, Bloomquist, Erik, Tang, Shenghui, Goldberg, Kirsten B., Sridhara, Rajeshwari, Ibrahim, Amna, Kim, Geoffrey, Kluetz, Paul, McKee, Amy, Pazdur, Richard
Cyhoeddwyd yn J Clin Oncol (2018)

State of the Science and Future Directions for Liquid Biopsies in Drug Development

gan Narayan, Preeti, Ghosh, Soma, Philip, Reena, Barrett, J. Carl, McCormack, Robert T., Odegaard, Justin I., R. Oxnard, Geoffrey, Pracht, Laurel J., Williams, P. Mickey, Kelloff, Gary J., Beaver, Julia A.
Cyhoeddwyd yn Oncologist (2020)

FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum‐Based Chemotherapy in Extensive Stage Small Cell Lung Cancer

gan Mathieu, Luckson, Shah, Sujay, Pai‐Scherf, Lee, Larkins, Erin, Vallejo, Jonathon, Li, Xiaoxue, Rodriguez, Lisa, Mishra‐Kalyani, Pallavi, Goldberg, Kirsten B., Kluetz, Paul G., Theoret, Marc R., Beaver, Julia A., Pazdur, Richard, Singh, Harpreet
Cyhoeddwyd yn Oncologist (2021)

US Food and Drug Administration regulatory updates in neuro-oncology

gan Mehta, Gautam U., Barone, Amy K., Bradford, Diana, Larkins, Erin, Kim, Janice, Pai-Scherf, Lee, Jaigirdar, Adnan, Shah, Mirat, Wedam, Suparna, Amiri-Kordestani, Laleh, Theoret, Marc R., Pazdur, Richard, Beaver, Julia A., Singh, Harpreet
Cyhoeddwyd yn J Neurooncol (2021)

Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis

gan Norsworthy, Kelly J., Mulkey, Flora, Scott, Emma C., Ward, Ashley F., Przepiorka, Donna, Charlab, Rosane, Dorff, Sarah, Deisseroth, Albert B., Kazandjian, Dickran, Sridhara, Rajeshwari, Beaver, Julia A., Farrell, Ann T., de Claro, R. Angelo, Pazdur, Richard
Cyhoeddwyd yn Clin Cancer Res (2020)

Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop—Workshop Proceedings

gan Horne, Hisani N., Roscoe, Donna, Litwack, E. David, Pathak, Anand, Pandey, Jai P., Gallagher, Pamela S., Koontz, Laura M., Schuck, Robert N., Lee, Eunice Y., Hu, Yun-Fu, Beaver, Julia A., Blumenthal, Gideon M., Philip, Reena
Cyhoeddwyd yn JCO Precis Oncol (2019)

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers

gan Jelovac, Danijela, Beaver, Julia A., Balukrishna, Sasidharan, Wong, Hong Yuen, Toro, Patricia Valda, Cimino-Mathews, Ashley, Argani, Pedram, Stearns, Vered, Jacobs, Lisa, VanDenBerg, Dustin, Kessler, Jill, Jeter, Stacie, Park, Ben H., Wolff, Antonio C.
Cyhoeddwyd 2013

FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy

gan Suzman, Daniel L., Agrawal, Sundeep, Ning, Yang‐min, Maher, V. Ellen, Fernandes, Laura L., Karuri, Stella, Tang, Shenghui, Sridhara, Rajeshwari, Schroeder, Jason, Goldberg, Kirsten B., Ibrahim, Amna, McKee, Amy E., Pazdur, Richard, Beaver, Julia A.
Cyhoeddwyd yn Oncologist (2018)

Analysis of BRCA2 loss-of-heterozygosity in tumor tissue using droplet digital PCR

gan Cochran, Rory L., Cravero, Karen, Chu, David, Erlanger, Bracha, Toro, Patricia Valda, Beaver, Julia A., Zabransky, Daniel J., Wong, Hong Yuen, Cidado, Justin, Croessmann, Sarah, Parsons, Heather, Kim, Minsoo, Wheelan, Sarah J., Argani, Pedram, Ho Park, Ben
Cyhoeddwyd 2014